Trials / Completed
CompletedNCT02708056
Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants
Sugammadex Given for the Reversal of Deep Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants: A Retrospective Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Baskent University · Academic / Other
- Sex
- All
- Age
- 1 Month – 12 Months
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of sugammadex in reversing profound neuromuscular block induced by rocuronium in infant patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2016-03-15
- Last updated
- 2016-03-15
Source: ClinicalTrials.gov record NCT02708056. Inclusion in this directory is not an endorsement.